Tech Company Financing Transactions

TRiCares Funding Round

TRiCares secured a $50 million Series D funding round on 7/25/2024. Backers included private investors.

Transaction Overview

Company Name
Announced On
7/25/2024
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series D
Investors
Proceeds Purpose
The company intends to use the funds to support upcoming US and EU clinical milestones for its transfemoral tricuspid heart valve replacement system, Topaz.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
27 Avenue de
Paris, 75001
FR
Phone
Undisclosed
Email Address
Overview
Developer of catheter-based valve replacement system designed for minimally invasive treatment of tricuspid valve regurgitation. The company's medical devices address tricuspid insufficiency through their anatomical conformation and their simplicity of use, enabling patients to avail of effective and lasting cures to the problem of tricuspid insufficiency.
Profile
TRiCares LinkedIn Company Profile
Social Media
TRiCares Company Twitter Account
Company News
TRiCares News
Facebook
TRiCares on Facebook
YouTube
TRiCares on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Helmut Straubinger
  Helmut Straubinger LinkedIn Profile  Helmut Straubinger Twitter Account  Helmut Straubinger News  Helmut Straubinger on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/25/2024: Jarvis venture capital transaction
Next: 7/25/2024: ShiftRX venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary